APO Research
Talk to an analyst

APO RESEARCH · REPORT

Latisse (Bimatoprost)

Bimatoprost (CAS 155206-00-1), also known as Latisse or Lumigan, belongs to a group of drugs called prostamides, which are synthetic structural analogs of prostaglandin. Bimatoprost, marketed by Allergan, is administered in both the ophthalmic solution and implant form. It has the ability to reduce ocular hypotension, proving effective in conditions such as ocular hypertension and glaucoma. Bimatoprost is also used to treat eyelash hypotrichosis, or sparse eyelash growth. It was initially approved by the FDA in 2001 for ocular hypertension and later approved for hypothrichosis in 2008, as eyelash growth became a desirable adverse effect for patients using this drug.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Bimatoprost (CAS 155206-00-1), also known as Latisse or Lumigan, belongs to a group of drugs called prostamides, which are synthetic structural analogs of prostaglandin. Bimatoprost, marketed by Allergan, is administered in both the ophthalmic solution and implant form. It has the ability to reduce ocular hypotension, proving effective in conditions such as ocular hypertension and glaucoma. Bimatoprost is also used to treat eyelash hypotrichosis, or sparse eyelash growth. It was initially approved by the FDA in 2001 for ocular hypertension and later approved for hypothrichosis in 2008, as eyelash growth became a desirable adverse effect for patients using this drug.

Selected research

Industry Growth & Trends

Global Latisse (Bimatoprost) Industry Growth and Trends Forecast to 2032

29 December 2025107 pages

Choose your research edition.

Industry ResearchLatisse (Bimatoprost) Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Latisse (Bimatoprost) Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Latisse (Bimatoprost) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Latisse (Bimatoprost) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Latisse (Bimatoprost) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Bimatoprost (CAS 155206-00-1), also known as Latisse or Lumigan, belongs to a group of drugs called prostamides, which are synthetic structural analogs of prostaglandin. Bimatoprost, marketed by Allergan, is administered in both the ophthalmic solution and implant form. It has the ability to reduce ocular hypotension, proving effective in conditions such as ocular hypertension and glaucoma. Bimatoprost is also used to treat eyelash hypotrichosis, or sparse eyelash growth. It was initially approved by the FDA in 2001 for ocular hypertension and later approved for hypothrichosis in 2008, as eyelash growth became a desirable adverse effect for patients using this drug.

Global Latisse (Bimatoprost) (CAS 155206-00-1) key players include Chirogate International, Cayman Pharma, Zhejiang Ausun, Everlight Chemical, and Lianmin Biochemical etc. Global top three players hold a share about 40%. North America is the largest market, with a share about 90%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Latisse (Bimatoprost) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Latisse (Bimatoprost) market size, estimates, and forecasts are presented in terms of sales volume (g) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Latisse (Bimatoprost) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Latisse (Bimatoprost).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Latisse (Bimatoprost) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Latisse (Bimatoprost) Market by Company

Cayman Pharma

Tecoland Corporation

TCS Group

Changzhou BOHIV

Zhejiang Ausun

Ansion Pharma

Lianmin Biochemical

Chirogate International

Everlight Chemical

GENTEC

Latisse (Bimatoprost) Segment by Purity

Below 99.5%

Other

Latisse (Bimatoprost) Segment by Application

Patented Product

General Products

Latisse (Bimatoprost) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Latisse (Bimatoprost) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Latisse (Bimatoprost) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Latisse (Bimatoprost).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Latisse (Bimatoprost) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Latisse (Bimatoprost) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Below 99.5% Table 2. Major Company of Other Table 3. Global Latisse (Bimatoprost) Sales by Purity (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Latisse (Bimatoprost) Sales by Purity (2021-2026) & (g) Table 5. Global Latisse (Bimatoprost) Sales Market Share in Volume by Purity (2021-2026) Table 6. Global Latisse (Bimatoprost) Sales by Purity (2021-2026) & (US$ Million) Table 7. Global Latisse (Bimatoprost) Sales Market Share in Value by Purity (2021-2026) Table 8. Global Latisse (Bimatoprost) Price by Purity (2021-2026) & (US$/g) Table 9. Global Latisse (Bimatoprost) Sales by Purity (2027-2032) & (g) Table 10. Global Latisse (Bimatoprost) Sales Market Share in Volume by Purity (2027-2032) Table 11. Global Latisse (Bimatoprost) Sales by Purity (2027-2032) & (US$ Million) Table 12. Global Latisse (Bimatoprost) Sales Market Share in Value by Purity (2027-2032) Table 13. Global Latisse (Bimatoprost) Price by Purity (2027-2032) & (US$/g) Table 14. North America Latisse (Bimatoprost) Sales by Purity (2021-2026) & (g) Table 15. North America Latisse (Bimatoprost) Sales by Purity (2021-2026) & (US$ Million) Table 16. Europe Latisse (Bimatoprost) Sales by Purity (2021-2026) & (g) Table 17. Europe Latisse (Bimatoprost) Sales by Purity (2021-2026) & (US$ Million) Table 18. Asia-Pacific Latisse (Bimatoprost) Sales by Purity (2021-2026) & (g) Table 19. Asia-Pacific Latisse (Bimatoprost) Sales by Purity (2021-2026) & (US$ Million) Table 20. Latin America Latisse (Bimatoprost) Sales by Purity (2021-2026) & (g) Table 21. Latin America Latisse (Bimatoprost) Sales by Purity (2021-2026) & (US$ Million) Table 22. Middle East and Africa Latisse (Bimatoprost) Sales by Purity (2021-2026) & (g) Table 23. Middle East and Africa Latisse (Bimatoprost) Sales by Purity (2021-2026) & (US$ Million) Table 24. Latisse (Bimatoprost) Industry Trends Table 25. Latisse (Bimatoprost) Industry Drivers Table 26. Latisse (Bimatoprost) Industry Opportunities and Challenges Table 27. Latisse (Bimatoprost) Industry Restraints Table 28. Global Latisse (Bimatoprost) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Latisse (Bimatoprost) Revenue Market Share by Company (2021-2026) Table 30. Global Latisse (Bimatoprost) Sales by Company (2021-2026) & (g) Table 31. Global Latisse (Bimatoprost) Sales Share by Company (2021-2026) Table 32. Global Latisse (Bimatoprost) Market Price by Company (2021-2026) & (US$/g) Table 33. Global Latisse (Bimatoprost) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Latisse (Bimatoprost) Major Company Production Sites and Headquarters Table 35. Global Latisse (Bimatoprost) Company, Product Type & Application Table 36. Global Latisse (Bimatoprost) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Latisse (Bimatoprost) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Latisse (Bimatoprost) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Latisse (Bimatoprost) Sales by Region (2021-2026) & (g) Table 41. Global Latisse (Bimatoprost) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Latisse (Bimatoprost) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Latisse (Bimatoprost) Sales Market Share in Value by Region (2021-2026) Table 44. Global Latisse (Bimatoprost) Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 45. Global Latisse (Bimatoprost) Sales by Region (2027-2032) & (g) Table 46. Global Latisse (Bimatoprost) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Latisse (Bimatoprost) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Latisse (Bimatoprost) Sales Market Share in Value by Region (2027-2032) Table 49. Global Latisse (Bimatoprost) Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 50. Global Latisse (Bimatoprost) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Latisse (Bimatoprost) Sales by Application (2021-2026) & (g) Table 52. Global Latisse (Bimatoprost) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Latisse (Bimatoprost) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Latisse (Bimatoprost) Sales Market Share in Value by Application (2021-2026) Table 55. Global Latisse (Bimatoprost) Price by Application (2021-2026) & (US$/g) Table 56. Global Latisse (Bimatoprost) Sales by Application (2027-2032) & (g) Table 57. Global Latisse (Bimatoprost) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Latisse (Bimatoprost) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Latisse (Bimatoprost) Sales Market Share in Value by Application (2027-2032) Table 60. Global Latisse (Bimatoprost) Price by Application (2027-2032) & (US$/g) Table 61. North America Latisse (Bimatoprost) Sales by Application (2021-2026) & (g) Table 62. North America Latisse (Bimatoprost) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Latisse (Bimatoprost) Sales by Application (2021-2026) & (g) Table 64. Europe Latisse (Bimatoprost) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Latisse (Bimatoprost) Sales by Application (2021-2026) & (g) Table 66. Asia-Pacific Latisse (Bimatoprost) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Latisse (Bimatoprost) Sales by Application (2021-2026) & (g) Table 68. Latin America Latisse (Bimatoprost) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Latisse (Bimatoprost) Sales by Application (2021-2026) & (g) Table 70. Middle East and Africa Latisse (Bimatoprost) Sales by Application (2021-2026) & (US$ Million) Table 71. Cayman Pharma Company Information Table 72. Cayman Pharma Business Overview Table 73. Cayman Pharma Latisse (Bimatoprost) Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 74. Cayman Pharma Latisse (Bimatoprost) Product Portfolio Table 75. Cayman Pharma Recent Development Table 76. Tecoland Corporation Company Information Table 77. Tecoland Corporation Business Overview Table 78. Tecoland Corporation Latisse (Bimatoprost) Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 79. Tecoland Corporation Latisse (Bimatoprost) Product Portfolio Table 80. Tecoland Corporation Recent Development Table 81. TCS Group Company Information Table 82. TCS Group Business Overview Table 83. TCS Group Latisse (Bimatoprost) Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 84. TCS Group Latisse (Bimatoprost) Product Portfolio Table 85. TCS Group Recent Development Table 86. Changzhou BOHIV Company Information Table 87. Changzhou BOHIV Business Overview Table 88. Changzhou BOHIV Latisse (Bimatoprost) Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 89. Changzhou BOHIV Latisse (Bimatoprost) Product Portfolio Table 90. Changzhou BOHIV Recent Development Table 91. Zhejiang Ausun Company Information Table 92. Zhejiang Ausun Business Overview Table 93. Zhejiang Ausun Latisse (Bimatoprost) Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 94. Zhejiang Ausun Latisse (Bimatoprost) Product Portfolio Table 95. Zhejiang Ausun Recent Development Table 96. Ansion Pharma Company Information Table 97. Ansion Pharma Business Overview Table 98. Ansion Pharma Latisse (Bimatoprost) Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 99. Ansion Pharma Latisse (Bimatoprost) Product Portfolio Table 100. Ansion Pharma Recent Development Table 101. Lianmin Biochemical Company Information Table 102. Lianmin Biochemical Business Overview Table 103. Lianmin Biochemical Latisse (Bimatoprost) Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 104. Lianmin Biochemical Latisse (Bimatoprost) Product Portfolio Table 105. Lianmin Biochemical Recent Development Table 106. Chirogate International Company Information Table 107. Chirogate International Business Overview Table 108. Chirogate International Latisse (Bimatoprost) Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 109. Chirogate International Latisse (Bimatoprost) Product Portfolio Table 110. Chirogate International Recent Development Table 111. Everlight Chemical Company Information Table 112. Everlight Chemical Business Overview Table 113. Everlight Chemical Latisse (Bimatoprost) Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 114. Everlight Chemical Latisse (Bimatoprost) Product Portfolio Table 115. Everlight Chemical Recent Development Table 116. GENTEC Company Information Table 117. GENTEC Business Overview Table 118. GENTEC Latisse (Bimatoprost) Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 119. GENTEC Latisse (Bimatoprost) Product Portfolio Table 120. GENTEC Recent Development Table 121. North America Latisse (Bimatoprost) Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 122. North America Latisse (Bimatoprost) Sales by Country (2021-2026) & (g) Table 123. North America Latisse (Bimatoprost) Sales Market Share by Country (2021-2026) Table 124. North America Latisse (Bimatoprost) Sales Forecast by Country (2027-2032) & (g) Table 125. North America Latisse (Bimatoprost) Sales Market Share Forecast by Country (2027-2032) Table 126. North America Latisse (Bimatoprost) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Latisse (Bimatoprost) Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Latisse (Bimatoprost) Market Share by Country (2021-2026) Table 129. North America Latisse (Bimatoprost) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Latisse (Bimatoprost) Market Share Forecast by Country (2027-2032) Table 131. Europe Latisse (Bimatoprost) Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 132. Europe Latisse (Bimatoprost) Sales by Country (2021-2026) & (g) Table 133. Europe Latisse (Bimatoprost) Sales Market Share by Country (2021-2026) Table 134. Europe Latisse (Bimatoprost) Sales Forecast by Country (2027-2032) & (g) Table 135. Europe Latisse (Bimatoprost) Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Latisse (Bimatoprost) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Latisse (Bimatoprost) Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Latisse (Bimatoprost) Market Share by Country (2021-2026) Table 139. Europe Latisse (Bimatoprost) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Latisse (Bimatoprost) Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Latisse (Bimatoprost) Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Latisse (Bimatoprost) Sales by Country (2021-2026) & (g) Table 143. Asia-Pacific Latisse (Bimatoprost) Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Latisse (Bimatoprost) Sales Forecast by Country (2027-2032) & (g) Table 145. Asia-Pacific Latisse (Bimatoprost) Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Latisse (Bimatoprost) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Latisse (Bimatoprost) Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Latisse (Bimatoprost) Market Share by Country (2021-2026) Table 149. Asia-Pacific Latisse (Bimatoprost) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Latisse (Bimatoprost) Market Share Forecast by Country (2027-2032) Table 151. Latin America Latisse (Bimatoprost) Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 152. Latin America Latisse (Bimatoprost) Sales by Country (2021-2026) & (g) Table 153. Latin America Latisse (Bimatoprost) Sales Market Share by Country (2021-2026) Table 154. Latin America Latisse (Bimatoprost) Sales Forecast by Country (2027-2032) & (g) Table 155. Latin America Latisse (Bimatoprost) Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Latisse (Bimatoprost) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Latisse (Bimatoprost) Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Latisse (Bimatoprost) Market Share by Country (2021-2026) Table 159. Latin America Latisse (Bimatoprost) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Latisse (Bimatoprost) Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Latisse (Bimatoprost) Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Latisse (Bimatoprost) Sales by Country (2021-2026) & (g) Table 163. Middle East and Africa Latisse (Bimatoprost) Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Latisse (Bimatoprost) Sales Forecast by Country (2027-2032) & (g) Table 165. Middle East and Africa Latisse (Bimatoprost) Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Latisse (Bimatoprost) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Latisse (Bimatoprost) Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Latisse (Bimatoprost) Market Share by Country (2021-2026) Table 169. Middle East and Africa Latisse (Bimatoprost) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Latisse (Bimatoprost) Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Latisse (Bimatoprost) Distributors List Table 174. Latisse (Bimatoprost) Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Latisse (Bimatoprost) Image Figure 2. Global Latisse (Bimatoprost) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Latisse (Bimatoprost) Market Size (2021-2032) & (US$ Million) Figure 4. Global Latisse (Bimatoprost) Sales (2021-2032) & (g) Figure 5. Below 99.5% Image Figure 6. Global Below 99.5% Sales YoY Growth (2021-2032) & (g) Figure 7. Other Image Figure 8. Global Other Sales YoY Growth (2021-2032) & (g) Figure 9. Global Latisse (Bimatoprost) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Latisse (Bimatoprost) Market Share by Type 2025 VS 2032 Figure 11. North America Latisse (Bimatoprost) Sales Market Share in Volume by Type in 2025 Figure 12. North America Latisse (Bimatoprost) Sales Market Share in Value by Type in 2025 Figure 13. Europe Latisse (Bimatoprost) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Latisse (Bimatoprost) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Latisse (Bimatoprost) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Latisse (Bimatoprost) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Latisse (Bimatoprost) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Latisse (Bimatoprost) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Latisse (Bimatoprost) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Latisse (Bimatoprost) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Latisse (Bimatoprost) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Patented Product Image Figure 24. Global Patented Product Sales YoY Growth (2021-2032) & (g) Figure 25. General Products Image Figure 26. Global General Products Sales YoY Growth (2021-2032) & (g) Figure 27. Global Latisse (Bimatoprost) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Latisse (Bimatoprost) Market Share by Application 2025 VS 2032 Figure 29. North America Latisse (Bimatoprost) Sales Market Share in Volume by Application in 2025 Figure 30. North America Latisse (Bimatoprost) Sales Market Share in Value by Application in 2025 Figure 31. Europe Latisse (Bimatoprost) Sales Market Share in Volume by Application in 2025 Figure 32. Europe Latisse (Bimatoprost) Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Latisse (Bimatoprost) Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Latisse (Bimatoprost) Sales Market Share in Value by Application in 2025 Figure 35. Latin America Latisse (Bimatoprost) Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Latisse (Bimatoprost) Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Latisse (Bimatoprost) Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Latisse (Bimatoprost) Sales Market Share in Value by Application in 2025 Figure 39. North America Latisse (Bimatoprost) Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 40. North America Latisse (Bimatoprost) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Latisse (Bimatoprost) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Latisse (Bimatoprost) Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Latisse (Bimatoprost) Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 44. Europe Latisse (Bimatoprost) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Latisse (Bimatoprost) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Latisse (Bimatoprost) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Latisse (Bimatoprost) Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 48. Asia-Pacific Latisse (Bimatoprost) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Latisse (Bimatoprost) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Latisse (Bimatoprost) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Latisse (Bimatoprost) Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 52. Latin America Latisse (Bimatoprost) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Latisse (Bimatoprost) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Latisse (Bimatoprost) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Latisse (Bimatoprost) Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 56. Middle East and Africa Latisse (Bimatoprost) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Latisse (Bimatoprost) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Latisse (Bimatoprost) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latisse (Bimatoprost) Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Latisse (Bimatoprost) Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Below 99.5%
  • Other
Applications
  • Patented Product
  • General Products
Companies covered
  • Cayman Pharma
  • Tecoland Corporation
  • TCS Group
  • Changzhou BOHIV
  • Zhejiang Ausun
  • Ansion Pharma
  • Lianmin Biochemical
  • Chirogate International
  • Everlight Chemical
  • GENTEC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Latisse (Bimatoprost) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Latisse (Bimatoprost) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Latisse (Bimatoprost) Market by Purity
  6. 1.3.1 Below 99.5%
  7. 1.3.2 Other
  8. 1.4 Global Latisse (Bimatoprost) Market Size by Purity
  9. 1.4.1 Global Latisse (Bimatoprost) Market Size Overview by Purity (2021-2032)
  10. 1.4.2 Global Latisse (Bimatoprost) Historic Market Size Review by Purity (2021-2026)
  11. 1.4.3 Global Latisse (Bimatoprost) Forecasted Market Size by Purity (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Latisse (Bimatoprost) Sales Breakdown by Purity (2021-2026)
  14. 1.5.2 Europe Latisse (Bimatoprost) Sales Breakdown by Purity (2021-2026)
  15. 1.5.3 Asia-Pacific Latisse (Bimatoprost) Sales Breakdown by Purity (2021-2026)
  16. 1.5.4 South America Latisse (Bimatoprost) Sales Breakdown by Purity (2021-2026)
  17. 1.5.5 Middle East and Africa Latisse (Bimatoprost) Sales Breakdown by Purity (2021-2026)
2 Global Market Dynamics
  1. 2.1 Latisse (Bimatoprost) Industry Trends
  2. 2.2 Latisse (Bimatoprost) Industry Drivers
  3. 2.3 Latisse (Bimatoprost) Industry Opportunities and Challenges
  4. 2.4 Latisse (Bimatoprost) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Latisse (Bimatoprost) Revenue (2021-2026)
  2. 3.2 Global Top Players by Latisse (Bimatoprost) Sales (2021-2026)
  3. 3.3 Global Top Players by Latisse (Bimatoprost) Price (2021-2026)
  4. 3.4 Global Latisse (Bimatoprost) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Latisse (Bimatoprost) Major Company Production Sites & Headquarters
  6. 3.6 Global Latisse (Bimatoprost) Company, Product Type & Application
  7. 3.7 Global Latisse (Bimatoprost) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Latisse (Bimatoprost) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Latisse (Bimatoprost) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Latisse (Bimatoprost) Tier 1, Tier 2, and Tier 3
4 Latisse (Bimatoprost) Regional Status and Outlook
  1. 4.1 Global Latisse (Bimatoprost) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Latisse (Bimatoprost) Historic Market Size by Region
  3. 4.2.1 Global Latisse (Bimatoprost) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Latisse (Bimatoprost) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Latisse (Bimatoprost) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Latisse (Bimatoprost) Forecasted Market Size by Region
  7. 4.3.1 Global Latisse (Bimatoprost) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Latisse (Bimatoprost) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Latisse (Bimatoprost) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Latisse (Bimatoprost) by Application
  1. 5.1 Latisse (Bimatoprost) Market by Application
  2. 5.1.1 Patented Product
  3. 5.1.2 General Products
  4. 5.2 Global Latisse (Bimatoprost) Market Size by Application
  5. 5.2.1 Global Latisse (Bimatoprost) Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Latisse (Bimatoprost) Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Latisse (Bimatoprost) Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Latisse (Bimatoprost) Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Latisse (Bimatoprost) Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Latisse (Bimatoprost) Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Latisse (Bimatoprost) Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Latisse (Bimatoprost) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Cayman Pharma
  2. 6.1.1 Cayman Pharma Company Information
  3. 6.1.2 Cayman Pharma Business Overview
  4. 6.1.3 Cayman Pharma Latisse (Bimatoprost) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Cayman Pharma Latisse (Bimatoprost) Product Portfolio
  6. 6.1.5 Cayman Pharma Recent Developments
  7. 6.2 Tecoland Corporation
  8. 6.2.1 Tecoland Corporation Company Information
  9. 6.2.2 Tecoland Corporation Business Overview
  10. 6.2.3 Tecoland Corporation Latisse (Bimatoprost) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Tecoland Corporation Latisse (Bimatoprost) Product Portfolio
  12. 6.2.5 Tecoland Corporation Recent Developments
  13. 6.3 TCS Group
  14. 6.3.1 TCS Group Company Information
  15. 6.3.2 TCS Group Business Overview
  16. 6.3.3 TCS Group Latisse (Bimatoprost) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 TCS Group Latisse (Bimatoprost) Product Portfolio
  18. 6.3.5 TCS Group Recent Developments
  19. 6.4 Changzhou BOHIV
  20. 6.4.1 Changzhou BOHIV Company Information
  21. 6.4.2 Changzhou BOHIV Business Overview
  22. 6.4.3 Changzhou BOHIV Latisse (Bimatoprost) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Changzhou BOHIV Latisse (Bimatoprost) Product Portfolio
  24. 6.4.5 Changzhou BOHIV Recent Developments
  25. 6.5 Zhejiang Ausun
  26. 6.5.1 Zhejiang Ausun Company Information
  27. 6.5.2 Zhejiang Ausun Business Overview
  28. 6.5.3 Zhejiang Ausun Latisse (Bimatoprost) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zhejiang Ausun Latisse (Bimatoprost) Product Portfolio
  30. 6.5.5 Zhejiang Ausun Recent Developments
  31. 6.6 Ansion Pharma
  32. 6.6.1 Ansion Pharma Company Information
  33. 6.6.2 Ansion Pharma Business Overview
  34. 6.6.3 Ansion Pharma Latisse (Bimatoprost) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ansion Pharma Latisse (Bimatoprost) Product Portfolio
  36. 6.6.5 Ansion Pharma Recent Developments
  37. 6.7 Lianmin Biochemical
  38. 6.7.1 Lianmin Biochemical Company Information
  39. 6.7.2 Lianmin Biochemical Business Overview
  40. 6.7.3 Lianmin Biochemical Latisse (Bimatoprost) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lianmin Biochemical Latisse (Bimatoprost) Product Portfolio
  42. 6.7.5 Lianmin Biochemical Recent Developments
  43. 6.8 Chirogate International
  44. 6.8.1 Chirogate International Company Information
  45. 6.8.2 Chirogate International Business Overview
  46. 6.8.3 Chirogate International Latisse (Bimatoprost) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Chirogate International Latisse (Bimatoprost) Product Portfolio
  48. 6.8.5 Chirogate International Recent Developments
  49. 6.9 Everlight Chemical
  50. 6.9.1 Everlight Chemical Company Information
  51. 6.9.2 Everlight Chemical Business Overview
  52. 6.9.3 Everlight Chemical Latisse (Bimatoprost) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Everlight Chemical Latisse (Bimatoprost) Product Portfolio
  54. 6.9.5 Everlight Chemical Recent Developments
  55. 6.10 GENTEC
  56. 6.10.1 GENTEC Company Information
  57. 6.10.2 GENTEC Business Overview
  58. 6.10.3 GENTEC Latisse (Bimatoprost) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 GENTEC Latisse (Bimatoprost) Product Portfolio
  60. 6.10.5 GENTEC Recent Developments
7 North America by Country
  1. 7.1 North America Latisse (Bimatoprost) Sales by Country
  2. 7.1.1 North America Latisse (Bimatoprost) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Latisse (Bimatoprost) Sales by Country (2021-2026)
  4. 7.1.3 North America Latisse (Bimatoprost) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Latisse (Bimatoprost) Market Size by Country
  6. 7.2.1 North America Latisse (Bimatoprost) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Latisse (Bimatoprost) Market Size by Country (2021-2026)
  8. 7.2.3 North America Latisse (Bimatoprost) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Latisse (Bimatoprost) Sales by Country
  2. 8.1.1 Europe Latisse (Bimatoprost) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Latisse (Bimatoprost) Sales by Country (2021-2026)
  4. 8.1.3 Europe Latisse (Bimatoprost) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Latisse (Bimatoprost) Market Size by Country
  6. 8.2.1 Europe Latisse (Bimatoprost) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Latisse (Bimatoprost) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Latisse (Bimatoprost) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Latisse (Bimatoprost) Sales by Country
  2. 9.1.1 Asia-Pacific Latisse (Bimatoprost) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Latisse (Bimatoprost) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Latisse (Bimatoprost) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Latisse (Bimatoprost) Market Size by Country
  6. 9.2.1 Asia-Pacific Latisse (Bimatoprost) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Latisse (Bimatoprost) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Latisse (Bimatoprost) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Latisse (Bimatoprost) Sales by Country
  2. 10.1.1 South America Latisse (Bimatoprost) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Latisse (Bimatoprost) Sales by Country (2021-2026)
  4. 10.1.3 South America Latisse (Bimatoprost) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Latisse (Bimatoprost) Market Size by Country
  6. 10.2.1 South America Latisse (Bimatoprost) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Latisse (Bimatoprost) Market Size by Country (2021-2026)
  8. 10.2.3 South America Latisse (Bimatoprost) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Latisse (Bimatoprost) Sales by Country
  2. 11.1.1 Middle East and Africa Latisse (Bimatoprost) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Latisse (Bimatoprost) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Latisse (Bimatoprost) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Latisse (Bimatoprost) Market Size by Country
  6. 11.2.1 Middle East and Africa Latisse (Bimatoprost) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Latisse (Bimatoprost) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Latisse (Bimatoprost) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Latisse (Bimatoprost) Value Chain Analysis
  2. 12.1.1 Latisse (Bimatoprost) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Latisse (Bimatoprost) Production Mode & Process
  7. 12.2 Latisse (Bimatoprost) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Latisse (Bimatoprost) Distributors
  10. 12.2.3 Latisse (Bimatoprost) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst